GREGORY CRAMER: Open Payments
NPI 1700469814 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 18 payments from 10 companies in 2025. Trend: 2023 $106 · 2024 $13 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 4 | $254 |
| JAZZ PHARMACEUTICALS INC. | 1 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Alexion Pharmaceuticals, Inc. | 3 | $59 |
| Gilead Sciences, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
Products named: XT CDX, ZIIHERA, ULTOMIRIS, Trodelvy, KISQALI, SCEMBLIX, ENHERTU, PYRUKYND.
Industry payments across FL — which companies pay providers there.
